English

XBIOTECH INC.

EDGAR

XBIT Current report (8-K) · filed 2026-10-26

63 filing records in this dataset, filed from 2015-02-02 to 2026-10-26. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 110 million USD 2026-06-30 Source
Exact value

109500000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 30.5 million shares 2026-06-30 Source
Exact value

30487731 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

30487731 shares · 2025-06-30· Source
30487731 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-26.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 7.01 million

Prior period

−USD 38.53 million

2024-01-01 – 2024-12-31
Current period

−USD 45.54 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-45540000 − -38531000 = -7009000 USD

-38531000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-45540000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Year-over-year change in Net income: -7009000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -45540000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#883166 Filing: 000117184326001561 Input fundies:NetIncome: -38531000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#883860 Filing: 000117184326001561
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 8.96 million

Prior period

−USD 30.96 million

2024-01-01 – 2024-12-31
Current period

−USD 39.92 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-39920000 − -30963000 = -8957000 USD

-30963000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-39920000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Year-over-year change in Operating cash flow: -8957000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -39920000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#653467 Filing: 000117184326001561 Input fundies:OperatingCashFlow: -30963000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#654177 Filing: 000117184326001561
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-77.8%

Prior period

USD 1.3 million

2024-01-01 – 2024-12-31
Current period

USD 289,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

289000 − 1304000 = -1015000 USD

1304000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
289000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Year-over-year change in Capital expenditure: -1015000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 289000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#657692 Filing: 000117184326001561 Input fundies:CapitalExpenditure: 1304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#658546 Filing: 000117184326001561
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 21.14 million Exact value Exact value: -21138000 USD 2018-01-01 – 2018-12-31: -21138000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2018-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -21138000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21138000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184321001828/xbit20201231_10k.htm#1192423 Filing: 000117184321001828 The citation records this snapshot. The page link may show a newer release later.	−USD 16.54 million Exact value Exact value: -16537000 USD 2018-01-01 – 2018-12-31: -16537000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2018-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -16537000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16537000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184321001828/xbit20201231_10k.htm#943550 Filing: 000117184321001828 The citation records this snapshot. The page link may show a newer release later.	USD 122,000 Exact value Exact value: 122000 USD 2018-01-01 – 2018-12-31: 122000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2018-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 122000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 122000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184321001828/xbit20201231_10k.htm#947416 Filing: 000117184321001828 The citation records this snapshot. The page link may show a newer release later.	−USD 16.66 million Calculation and evidence -16537000 − 122000 USD Exact free cash flow: -16659000 USD 2018-01-01 – 2018-12-31: -16537000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 122000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2018-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -16659000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16537000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184321001828/xbit20201231_10k.htm#943550 Filing: 000117184321001828 Input fundies:CapitalExpenditure: 122000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184321001828/xbit20201231_10k.htm#947416 Filing: 000117184321001828 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 668.63 million Exact value Exact value: 668629000 USD 2019-01-01 – 2019-12-31: 668629000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2019-12-31 XBIOTECH INC. (edgar:1626878) Net Income: 668629000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 668629000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#1088956 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.	−USD 18.27 million Exact value Exact value: -18270000 USD 2019-01-01 – 2019-12-31: -18270000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2019-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -18270000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18270000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#855942 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.	USD 204,000 Exact value Exact value: 204000 USD 2019-01-01 – 2019-12-31: 204000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2019-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 204000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 204000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#859757 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.	−USD 18.47 million Calculation and evidence -18270000 − 204000 USD Exact free cash flow: -18474000 USD 2019-01-01 – 2019-12-31: -18270000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 204000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2019-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -18474000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18270000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#855942 Filing: 000117184322001904 Input fundies:CapitalExpenditure: 204000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#859757 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 11.22 million Exact value Exact value: -11221000 USD 2020-01-01 – 2020-12-31: -11221000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2020-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -11221000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11221000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#1088380 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.	−USD 65.15 million Exact value Exact value: -65149000 USD 2020-01-01 – 2020-12-31: -65149000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2020-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -65149000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -65149000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#855321 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.	USD 3.73 million Exact value Exact value: 3727000 USD 2020-01-01 – 2020-12-31: 3727000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2020-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 3727000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3727000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#859146 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.	−USD 68.88 million Calculation and evidence -65149000 − 3727000 USD Exact free cash flow: -68876000 USD 2020-01-01 – 2020-12-31: -65149000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 3727000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2020-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -68876000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -65149000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#855321 Filing: 000117184322001904 Input fundies:CapitalExpenditure: 3727000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184322001904/xbit20211231_10k.htm#859146 Filing: 000117184322001904 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 17.41 million Exact value Exact value: -17414000 USD 2021-01-01 – 2021-12-31: -17414000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2021-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -17414000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17414000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184323001705/xbit20221231_10k.htm#875071 Filing: 000117184323001705 The citation records this snapshot. The page link may show a newer release later.	USD 69.45 million Exact value Exact value: 69445000 USD 2021-01-01 – 2021-12-31: 69445000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2021-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: 69445000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 69445000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184323001705/xbit20221231_10k.htm#699549 Filing: 000117184323001705 The citation records this snapshot. The page link may show a newer release later.	USD 3.53 million Exact value Exact value: 3525000 USD 2021-01-01 – 2021-12-31: 3525000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2021-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 3525000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3525000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184323001705/xbit20221231_10k.htm#702105 Filing: 000117184323001705 The citation records this snapshot. The page link may show a newer release later.	USD 65.92 million Calculation and evidence 69445000 − 3525000 USD Exact free cash flow: 65920000 USD 2021-01-01 – 2021-12-31: 69445000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3525000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2021-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: 65920000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 69445000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184323001705/xbit20221231_10k.htm#699549 Filing: 000117184323001705 Input fundies:CapitalExpenditure: 3525000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184323001705/xbit20221231_10k.htm#702105 Filing: 000117184323001705 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 32.9 million Exact value Exact value: -32900000 USD 2022-01-01 – 2022-12-31: -32900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2022-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -32900000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32900000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184324001382/xbit20231231_10k.htm#934210 Filing: 000117184324001382 The citation records this snapshot. The page link may show a newer release later.	−USD 14.82 million Exact value Exact value: -14824000 USD 2022-01-01 – 2022-12-31: -14824000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2022-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -14824000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14824000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184324001382/xbit20231231_10k.htm#718889 Filing: 000117184324001382 The citation records this snapshot. The page link may show a newer release later.	USD 585,000 Exact value Exact value: 585000 USD 2022-01-01 – 2022-12-31: 585000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2022-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 585000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 585000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184324001382/xbit20231231_10k.htm#723086 Filing: 000117184324001382 The citation records this snapshot. The page link may show a newer release later.	−USD 15.41 million Calculation and evidence -14824000 − 585000 USD Exact free cash flow: -15409000 USD 2022-01-01 – 2022-12-31: -14824000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 585000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2022-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -15409000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14824000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184324001382/xbit20231231_10k.htm#718889 Filing: 000117184324001382 Input fundies:CapitalExpenditure: 585000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184324001382/xbit20231231_10k.htm#723086 Filing: 000117184324001382 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 24.56 million Exact value Exact value: -24557000 USD 2023-01-01 – 2023-12-31: -24557000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2023-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -24557000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24557000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184325001527/xbit20241231_10k.htm#875035 Filing: 000117184325001527 The citation records this snapshot. The page link may show a newer release later.	−USD 18.73 million Exact value Exact value: -18725000 USD 2023-01-01 – 2023-12-31: -18725000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2023-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -18725000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18725000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184325001527/xbit20241231_10k.htm#647276 Filing: 000117184325001527 The citation records this snapshot. The page link may show a newer release later.	USD 362,000 Exact value Exact value: 362000 USD 2023-01-01 – 2023-12-31: 362000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2023-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 362000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 362000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184325001527/xbit20241231_10k.htm#651413 Filing: 000117184325001527 The citation records this snapshot. The page link may show a newer release later.	−USD 19.09 million Calculation and evidence -18725000 − 362000 USD Exact free cash flow: -19087000 USD 2023-01-01 – 2023-12-31: -18725000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 362000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2023-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -19087000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18725000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184325001527/xbit20241231_10k.htm#647276 Filing: 000117184325001527 Input fundies:CapitalExpenditure: 362000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184325001527/xbit20241231_10k.htm#651413 Filing: 000117184325001527 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 38.53 million Exact value Exact value: -38531000 USD 2024-01-01 – 2024-12-31: -38531000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2024-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -38531000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38531000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#883860 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.	−USD 30.96 million Exact value Exact value: -30963000 USD 2024-01-01 – 2024-12-31: -30963000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2024-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -30963000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30963000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#654177 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.	USD 1.3 million Exact value Exact value: 1304000 USD 2024-01-01 – 2024-12-31: 1304000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2024-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 1304000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#658546 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.	−USD 32.27 million Calculation and evidence -30963000 − 1304000 USD Exact free cash flow: -32267000 USD 2024-01-01 – 2024-12-31: -30963000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1304000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2024-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -32267000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30963000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#654177 Filing: 000117184326001561 Input fundies:CapitalExpenditure: 1304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#658546 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 45.54 million Exact value Exact value: -45540000 USD 2025-01-01 – 2025-12-31: -45540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Net Income: -45540000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45540000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#883166 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.	−USD 39.92 million Exact value Exact value: -39920000 USD 2025-01-01 – 2025-12-31: -39920000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Operating Cash Flow: -39920000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39920000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#653467 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.	USD 289,000 Exact value Exact value: 289000 USD 2025-01-01 – 2025-12-31: 289000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Capital Expenditure: 289000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 289000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#657692 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.	−USD 40.21 million Calculation and evidence -39920000 − 289000 USD Exact free cash flow: -40209000 USD 2025-01-01 – 2025-12-31: -39920000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 289000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · XBIOTECH INC. · 2025-12-31 XBIOTECH INC. (edgar:1626878) Free cash flow: -40209000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1626878?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -39920000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#653467 Filing: 000117184326001561 Input fundies:CapitalExpenditure: 289000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1626878/000117184326001561/xbit20251231_10k.htm#657692 Filing: 000117184326001561 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 2,871 latest values · 2,873 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001626878, 1626878, XBIT, edgar:1626878, xbit

Also known as XBIOTECH INC., XBiotech Inc.

XBIOTECH INC.

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation